Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market Inclining Growth by 2021-2028| WEX Pharmaceuticals, Asahi Kasei, MediciNova, Achelios Therapeutics, Esteve, ChromaDex, Apollo Endosurgery, Hoffmann-La Roche, Midatech/DARA, Lee's Pharmaceutical Limi

Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most frequent side effects caused by antineoplastic agents, with a prevalence from 19% to over 85%. Clinically, CIPN is a mostly sensory neuropathy that may be accompanied by motor and autonomic changes of varying intensity and duration.

Many things can cause neuropathy, including certain chemotherapy drugs. Damage to peripheral nerves by these drugs is called chemotherapy-induced peripheral neuropathy, abbreviated as CIPN. CIPN isn't uncommon. Of people with cancer who are treated with chemotherapy, about 30 to 40 percent develop CIPN.

Neuropathy can be considered a disability by the SSA. In order to qualify for Social Security disability benefits with neuropathy, you need to meet both the work and medical guidelines that are set by the SSA.

Neuropathy can be extremely painful, but it is not usually permanent. For most people, symptoms go away after they stop chemotherapy. Sometimes it takes a few months for symptoms to fade. A 2014 study found that 30 percent of people still had symptoms of CIPN 6 months or longer after stopping chemotherapy.

Treatment is mostly given to relieve the pain that can come with CIPN. Some of the drugs used include: Steroids for a short time until a long-term treatment plan is in place. Patches or creams of numbing medicine that can be put right on the painful area (for example, lidocaine patches or capsaicin cream).

Request a sample copy of report @ https://www.reportconsultant.com/request_sample.php?id=90810

Key Players of Global Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market:
PledOx/Solasia, WEX Pharmaceuticals, Asahi Kasei, MediciNova, Achelios Therapeutics, Esteve, ChromaDex, Apollo Endosurgery (Lpath), Hoffmann-La Roche, Midatech/DARA, Lee's Pharmaceutical Limited, Novartis, Relief Therapeutics and others.

Report Consultant has recently set forth the incorporation of a new probe to its database titled Global Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market. This report delivers key insights and providing a competitive advantage to clients through this research study. Global Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market report provides an understanding of the subject matter and has been assembled by suing primary and secondary research techniques. These two methods are anticipated towards collaborating precise data relating to the market dynamics, historical events, and the present scenario.

The Global Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market study provides an in-depth analysis of the information regarding key drivers, restraints, and opportunities with a detailed impact analysis. Porter’s five forces analysis highlights the potency of suppliers & buyers and describes the competitive scenario of the Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market, which is expected to facilitate efficient business planning. Value chain analysis provides key inputs on role of key intermediaries involved, which is anticipated to assist stakeholders in devising appropriate strategies.

Global Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market segmentation by treatment:
• Electrical nerve stimulation
• Occupational therapy
• Physical therapy
• Relaxation therapy
• Guided imagery
• Distraction
• Acupuncture
• Biofeedback
Global Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market segmentation by region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle east & Africa

Enquiry Before Buying @ https://www.reportconsultant.com/enquiry_before_buying.php?id=90810

Table of Content:
Chapter 1- Global Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market overview
Chapter 2- Offers review from customers
Chapter 3- Different approaches for exploring the Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market opportunities
Chapter 4- Holistic snapshot of the competitive landscape
Chapter 5- Market segmentation across the globe
Chapter 6- Fragmentation of Global Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market over the regions
Chapter 7- Detailed analysis of key players, vendors, and traders
Chapter 8- Informative data for strategic planning of business
Chapter 9- Risk evaluation method
Chapter 10- Prerequisite of Global Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market
Chapter 11- Forecast the futuristic developments and upcoming competitors
Chapter 12- Appendix
Continued….

If you have any requirement, let us know and we will customize report according to your need.

Rebecca Parker
(Report Consultant)
Contact No: +81-368444299
sales@reportconsultant.com
www.reportconsultant.com

About Us:

Report Consultant - A worldwide pacesetter in analytics, research and advisory that can assist you to renovate your business and modify your approach. With us, you will learn to take decisions intrepidly by taking calculative risks leading to lucrative business in the ever-changing market. We make sense of drawbacks, opportunities, circumstances, estimations and information using our experienced skills and verified methodologies.
Our research reports will give you the most realistic and incomparable experience of revolutionary market solutions. We have effectively steered business all over the world through our market research reports with our predictive nature and are exceptionally positioned to lead digital transformations. Thus, we craft greater value for clients by presenting progressive opportunities in the global futuristic market.

This release was published on openPR.